Expert Interview
Understanding of the Canine Diarrhea market in the US. Size of market, current options, owner willingness to pay, and review of Canalevia pilot study data
Ticker(s): JAGXVet with a large practice. Ideally one that was involved in the pilot trial for the Canalevia completed in Feb of 2015.
Please describe your clinic and how many dogs you treat in a given month for diarrhea.
Added By: joe_mccannWhat do you typically do for acute diarrhea in canines?
Added By: joe_mccannWhat's the effectiveness and cost of current treatments for canines?
Added By: joe_mccannWith 50% of canines resolving on placebo vs. 91% on Canavelia, how necessary a medicine do you think it is? What % of the canines you treat would you recommend using this product?
Added By: joe_mccannCan you give us a range for the potential price of this treatment that you think would be widely acceptable? Can you use comparable treatments currently purchased by pet owners and the reactions they have to hearing them?
Added By: joe_mccannIs there any mitigation of health care costs for pets that you think are common or relevant?
Added By: joe_mccannHow big do you think the market really is for Canalevia?
Added By: joe_mccannAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
